Quantitative Investment Management, LLC Acelrx Pharmaceuticals Inc Transaction History

Quantitative Investment Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 10, 2018	SELL	$2.13 - $4.2 $85,839 - $169,260	-40,300 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$1.7 - $2.35 $26,010 - $35,955	15,300 Added 61.2%	40,300 $84,000
Q4 2017 Feb 14, 2018	BUY	$1.75 - $5.5 $43,750 - $137,500	25,000	25,000 $50,000

Ticker ACRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 7,366,600
Market Cap $8.32M
Description
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed ...

Get notified when there are updates to the investment portfolio of Quantitative Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Quantitative Investment Management, LLC with notifications on news.